There has been a significant increase in research on illicit and potentially addictive substances for their possible therapeutic purposes recently, especially in the field of psychiatry. From ketamine to psilocybin, from marijuana to kratom, the interest in these areas continues to grow.
The Wisconsin Psychiatric Association invites you to its 2018 Annual Conference to learn about the most recent research as well as the controversies that accompany these drugs.
The conference kicks off on Thursday, March 8, with a reception, dinner and presentation entitled “An Update on the Challenges of Treating Addictive Disorders.” This theme will be shared throughout the conference by local and national speakers, including discussion of current evidence, research processes and possible addiction concerns. Saturday’s presentations by Kevin Hill, MD, MHS, from Harvard will provide timely updates in the use of medical marijuana and the treatment of cannabis use disorders.
Thursday’s featured speaker, Rebecca Brendel, MD, JD, from Harvard’s Center for Bioethics, will address the Goldwater Rule, another controversial topic in psychiatry. Lectures on other emerging treatments, an update on autism treatment, and the treatment of pain in patients with psychiatric disorders are also part of the lineup, as is the Annual Resident Clinical Vignette Competition.
The conference has been approved for 11.75 AMA PRA Category 1 Credits™. Click here for more information or to register online.
Back to February 15, 2018 Medigram